Equity
€134,676 ▲ 61.8%
ARDS paid out €50,000 in dividends. That is 31% of the 2025 profit.
ARDS
Lifetime
4 annual accounts with figures on one time axispeak €291,551 (2025)
€291,551▲ 42.8%
lowest -€41,067 (2023)
€161,431▲ 195%
peak €134,676 (2025)
€134,676▲ 61.8%
€339,024▼ 2.0%
Board2 names since 2022
2 directors and 1 other
Documentsfilings and deeds
30-01-20261 day before the deadline
2025financial year
Gross margin from €204,113 to €291,551Result from €54,640 to €161,431Dividend €50,000Equity from €83,245 to €134,676
Key points
from the 2025 annual accountsResult
€161,431 ▲ 195%
The result rose in 2025 from €54,640 to €161,431.
Turnover
≈ €440,000 estimated
The accounts state no turnover.
Debts
€339,024 72% of the balance sheet
Financial debts 23%Suppliers 0%Taxes and wages 5%Other 72%
Of this, €262,431 falls due within a year.
Filings
4 annual accounts since 2022
The last four annual accounts were filed 0 to 47 days before the end of the period.
Starting capital
€2,000 200 shares
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 1,603 companies had the same profile as ARDS has now. Each dot stands for 5 companies, two years later.
96.4%
were still trading
1.1%
stopped another way
2.3%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,603 companies, not a prediction for ARDS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director
Director
- founderdeed of 25-02-2022
- founderdeed of 25-02-2022
Recent changes
Registered office moved from Liège to Hermalle sous-Argenteau
New registered office: Rue Jean Verkruyts 45 à 4681 Hermalle sous-Argenteau · Previous registered office: Quai Godefroid-Kurth 23A/0082, 4020 Liège · Board meeting of 10-12-2025 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0782515232
Incorporation
Founding capital of €2,000, 200 shares · Founders: and · Appointments: (director) and (director) · published on 25-02-2022 · Gazette deed
First establishment
Rue Jean Verkruyts 45, Oupeye
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| ARDS Oupeye | €473,700 | €291,551 | 28.4% | - |
| OPHTALMOLOGUE NIZETTE GAËLLE Liège | €492,869 | €277,209 | 22.5% | - |
| Chirurgie Plastique Esthétique AL-AZZEH Trooz | €413,133 | €267,487 | 18.2% | - |
| DChirnoaga Saint-Josse-ten-Noode | €501,857 | €290,727 | 0.2% | - |
| Dr. Bernd Lannau - Reconstructieve en esthetische chirurgie Ghent | €511,802 | €297,374 | 87.6% | - |
| Dokter Vincent Eggerding De Haan | €431,550 | €285,070 | 68.8% | - |
| Dr. Bastiaan Sol, Endocrinologie Ghent | €452,475 | €303,130 | 0.2% | - |
These companies have the same main activity as ARDS: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €413,000 and €512,000, founded in 2022.
Official details
Source: KBO- Status
- Active since 23-02-2022Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.328.328.1174681 Oupeye, since 23-02-2022
- Financial year end
- 30 June
- Peppol
- Reachable since 17-12-2025
Annual accounts to 30-06-2025
- €473,700▲ 10.3%
- Filing
- Filed on 30-01-2026, 1 day before the end of the filing period
Insights on ARDS
Solvency rose in 2025 from 19.4% to 28.4% because of the retained profit.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about ARDS
- What is the company number of ARDS?
- The company number of ARDS is 0782.515.232. The VAT number is the same number with BE in front: BE 0782.515.232.
- Where is ARDS based?
- The registered office is at Rue Jean Verkruyts 45, 4681 Oupeye.Company details
- What does ARDS do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of ARDS?
- ARDS is a private limited company (BV).
- When was ARDS founded?
- ARDS was founded on 23-02-2022.
- Is ARDS still active?
- Yes, ARDS is an active enterprise in the KBO register.
- What is the turnover of ARDS?
- The turnover in financial year 2025 is ≈ €440,000. This figure is estimated from the gross margin of €291,551 and 31 comparable companies (NACE 86220). It probably lies between €390,000 and €610,000.Financials
- Is ARDS profitable?
- In financial year 2025, ARDS made a profit of €161,431.
- Where can I find the annual accounts of ARDS?
- ARDS filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of ARDS due?
- ARDS must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.